CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenue	$ 595,271	$ 608,181	$ 27,111
Costs and expenses
Cost of revenue	1,936,066	1,646,086	154,897
Research and development	937,012	821,512	750,185
Selling, general and administrative	797,235	734,574	652,475
Restructuring charges	24,546	0	0
Total cost and expenses	3,694,859	3,202,172	1,557,557
Loss from operations	(3,099,588)	(2,593,991)	(1,530,446)
Other income (expense), net
Change in fair value of forward contracts	0	0	(454,546)
Change in fair value of equity securities	5,999	0	0
Transaction costs expensed	0	0	(2,717)
Interest income	204,274	56,756	0
Interest expense	(24,915)	(30,596)	(1,374)
Other income (expense), net	(90)	9,532	(893)
Total other income (expense), net	272,194	1,289,910	(1,049,266)
Loss before provision for income taxes	(2,827,394)	(1,304,081)	(2,579,712)
Provision for income taxes	1,026	379	49
Net loss	(2,828,420)	(1,304,460)	(2,579,761)
Deemed dividend related to the issuance of Series E convertible preferred stock	0	0	(2,167,332)
Net loss attributable to common stockholders, basic	(2,828,420)	(1,304,460)	(4,747,093)
Change in fair value of dilutive warrants	0	(1,254,218)	0
Net loss attributable to common stockholders, diluted	$ (2,828,420)	$ (2,558,678)	$ (4,747,093)
Weighted average shares outstanding attributable to common stockholders
Basic (in shares)	2,081,772,622	1,678,346,079	740,393,759
Diluted (in shares)	2,081,772,622	1,693,258,608	740,393,759
Net loss per share attributable to common stockholders
Basic (in dollars per share)	$ (1.36)	$ (0.78)	$ (6.41)
Diluted (in dollars per share)	$ (1.36)	$ (1.51)	$ (6.41)
Other comprehensive income (loss)
Net unrealized gains (losses) on investments, net of tax	$ 12,669	$ (11,572)	$ 0
Foreign currency translation adjustments	3,753	0	0
Total other comprehensive income (loss)	16,422	(11,572)	0
Comprehensive loss	(2,811,998)	(1,316,032)	(2,579,761)
Deemed dividend related to the issuance of Series E convertible preferred stock	0	0	(2,167,332)
Comprehensive loss attributable to common stockholders	(2,811,998)	(1,316,032)	(4,747,093)
Change in fair value of convertible preferred stock warrant liability
Other income (expense), net
Change in fair value of stock warrant liability	0	0	(6,976)
Change in fair value of common stock warrant liability
Other income (expense), net
Change in fair value of stock warrant liability	$ 86,926	$ 1,254,218	$ (582,760)